NCT00326391View on ClinicalTrials.gov

A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

methylphenidate hydrochloride extended-release tablets

All Listed Sponsors
lead

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

NCT00326391 - A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder | Biotech Hunter | Biotech Hunter